Gingival Recession Market Report 2025

The gingival recession market size has grown strongly in recent years. It will grow from $3.09 billion in 2024 to $3.3 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth during the historic period can be attributed to factors such as the increasing aging population, growing awareness about oral healthcare, rising disposable income, the increasing importance of dental aesthetics, and the rising prevalence of periodontal disease.

The gingival recession market size is expected to see strong growth in the next few years. It will grow to $4.21 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The anticipated growth during the forecast period is driven by several factors, including an increased demand for non-invasive treatments, a heightened focus on physical appearance and dental imperfections, a rising preference for biological therapies, a growing pediatric population, and a surge in the demand for advanced cosmetic dental procedures. Key trends expected to shape the period include improvements in surgical techniques, technological progress in tissue regeneration, breakthroughs in dental technology, innovations in telemedicine and remote consultations, and developments in 3D imaging and computer-aided design.

The increasing awareness of oral health is expected to drive the growth of the gingival recession market in the coming years. Oral health encompasses the condition of the teeth, gums, and mouth, ensuring they are free from disease, pain, or infection, and promoting overall well-being. Growing awareness of oral health is fueled by greater access to information through digital media and healthcare campaigns, which highlight its impact on general health. Gingival recession, a visible and often painful sign of poor oral health, is leading people to learn more about its causes, prevention, and treatment, thus improving knowledge about oral hygiene practices. For example, a report from the Manchester Health and Wellbeing Board, published in January 2024, indicated that 78,230 children under 18 received treatment from an NHS dentist in Manchester between July 2022 and June 2023, marking a 20.8% increase from the previous year with 13,488 more children receiving care. As awareness of oral health grows, so does the demand for gingival recession treatments.

Major companies in the market are developing innovative solutions, such as injectable regenerative tissue advancement therapy. This therapy aims to enhance soft and hard tissue regeneration, improve treatment outcomes, and address existing gaps in oral healthcare. Injectable regenerative tissue therapy is a minimally invasive treatment that promotes tissue regeneration and natural healing, restoring both soft and hard tissues. For example, in February 2025, BioCellgraft, Inc., a US-based biotechnology and regenerative medicine company, introduced OraFyl. OraFyl’s injectable formulation stands out from traditional grafting methods in oral tissue regeneration. Unlike conventional surgical procedures that involve significant intervention and lengthy recovery times, OraFyl offers a minimally invasive approach to treat gum recession, papilla loss, and alveolar socket management. By utilizing a human connective tissue matrix (HCTM), it supports the body's natural healing process, potentially accelerating recovery, reducing discomfort, lowering treatment costs, and improving clinical results.

In January 2025, Branford Castle Partners, a US-based private equity firm, expanded its dental portfolio by acquiring Eastern Dental Management, for an undisclosed amount. This acquisition is part of Branford Castle's strategy of investing in companies with strong competitive advantages and leadership in specialized industries. Eastern Dental Management is a dental services company based in the US, offering treatments for various dental conditions, including gingival recession.

Major players in the gingival recession market are Cigna Health and Life Insurance Company, Procter & Gamble, AFLAC INCORPORATED, Colgate-Palmolive Company, Alfa-Perio Ltd, Zimmer Biomet Dental, Institut Straumann AG, LifeNet Health, BioHorizons, American Dental Association, Geistlich Pharma AG, Outsource Strategies International, Delta Dental of South Dakota, Laboratorios KIN, osteocom, Dentevim Dental Clinic, Uniqa Dental LTD., Focus Dental, Premiere Dental Care Center, and Rezotto production GmbH.

North America was the largest region in the gingival recession market in 2024. The regions covered in gingival recession report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the gingival recession market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Gingival recession is a dental condition where the gum tissue around the teeth recedes or wears away, exposing more of the tooth or its root. This can lead to increased sensitivity, a higher risk of cavities, and aesthetic concerns. The condition may be caused by factors such as aggressive brushing, periodontal disease, genetics, or misaligned teeth.

The primary treatment methods for gingival recession include soft tissue grafting, regenerative procedures, and the pinhole surgical technique (PST). Soft tissue grafting involves taking healthy gum tissue, often from the roof of the mouth, and attaching it to areas where the gums have receded. This procedure aims to cover exposed tooth roots, reduce sensitivity, and improve the appearance of the gums. Product types used in these treatments include tissue regenerative materials and bone grafting materials, which are utilized by various end-users such as hospitals, dental clinics, research institutes, and others.

The gingival recession market research report is one of a series of new reports that provides gingival recession market statistics, including gingival recession industry global market size, regional shares, competitors with a gingival recession market share, detailed gingival recession market segments, market trends and opportunities, and any further data you may need to thrive in the gingival recession industry. This gingival recession market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gingival recession market consists of revenues earned by entities providing services such as preventive services, cosmetic procedures, and restorative solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The gingival recession market also includes sales of gingival contouring lasers, pinhole surgical instruments, and desensitizing agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.